World Media

Dolly Parton helped pay for the COVID-19 vaccine

Dolly Parton

This week, U.S. company Moderna announced its coronavirus vaccine may be 94.5% effective against Covid-19, and Parton is namechecked in the preliminary report. Pfizer had announced on November 9 that its trial run determined its vaccine to be 90% effective. The singer donated $1 million to help fund Moderna's Covid-19 vaccine, which early results have shown to be 94.5 percent effective in preventing infection. In 2016, she pledged $1,000 month to every family left homeless by wildfires in her home state, Tennessee, as reported by New York Times. According to CNN, Rihanna and Jay-Z each donated $1 million through their respective foundations.

In April, the 9 to 5 songwriter and country music legend posted on Instagram that she donated $1 million to Vanderbilt University's Medical Center in honour of her friend, Dr Najj Abumrad, a professor of surgery whom she befriended many years ago after seeking treatment for injuries sustained during a auto accident.

Speaking with NBC News Tuesday morning after hearing the news about Moderna's vaccine, Parton indicated she was happy to hear that her donation made a difference.

Parton, who is 74, has a history of philanthropy, as CNBC points out.

"There are going to be 100 bad movies about the COVID pandemic but I'll only watch the one where the day is saved by Dolly Parton in a lab coat", one user joked.

As another teased, "Shakespeare may have written King Lear during the plague, but Dolly Parton funded a covid vaccine, dropped a Christmas album and a Christmas special".

Today, Parton posted to her Twitter account, "When I donated the money to the Covid fund I just wanted it to do good and evidently, it is! Let's just hope we can find a cure real soon", she said.

"I am making a donation of 1 million dollars to Vanderbilt towards that research and to encourage people that can afford it to make donations".

"She cares so much about helping others and we are very grateful for her ongoing support", said Jeff Balser, president and CEO of VUMC and Dean of the Vanderbilt University School of Medicine.